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Abstract 
Background: World Health Organization (WHO) data collection of Escherichia coli 
resistant to cephalosporin generation III already confirmed in 86 countries. Incredibly 
high carrier prevalence rates were also widely developed in Thailand, Egypt, and 
China. The Faculty of Medicine's research team at Jenderal Soedirman University, 
Purwokerto, discovered at the beginning of 2018 that Extended Spectrum β-Lactamase 
(ESBL) E. coli carriers throughout the 2015 class students were 26.8 percent. 
Objective: This research investigated the prevalence and associated factors of ESBL-
producing Enterobacteriaceae (EPE) asymptomatic carriers in the community. 
Methods: The participant fill a questionnaire, and samples were taken from rectal 
swabs using Amies transport medium (Labware Charuzu), and then models were 
analyzed using HiCrome ™ ESBL Agar Base (Himedia, India). Analysis of its 
Prevalence and Resistance Predictors used IBM SPSS Statistics Version 22.0 for 
Windows (Armonk, NY: IBM Corp). 
Results: The prevalence of EPE asymptomatic carriers in the community in 
Purwokerto was 66.7%. In the bivariate analysis, subjects who took antacids in the last 
eight weeks, history of hospitalization in the previous 12 months, the habit of 
consuming milk, yogurt, cheese, meat, seafood, and raw vegetables did not show any 
significant difference. Frequent chicken and freshwater fish consumption tended to be 
a risk factor for ESBL-producing Enterobacteriaceae with PR 1.462, 95% CI (1.115-
1.918); PR 1.666, 95% CI  (0.936-2.966); however, in the multivariate logistic 
regression analysis, this was not significant. 
Conclusion: The prevalence of EPE asymptomatic carriers in the community in 
Purwokerto is 66.7%. None of the studied variables was correlated with ESBL-
producing Enterobacteriaceae. However, ESBL remains an emerging antimicrobial 
resistance. 
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INTRODUCTION 
 Extended-spectrum β-Lactamase (ESBL) is an 
enzyme made by some bacteria. That enzyme can 
hydrolyze penicillin, first, second, third-generation 
cephalosporins, aztreonam (except cephamycin and 
carbapenem).1 The bacteria that produce the most ESBL 
are bacteria from the Enterobacteriaceae family, 
especially Escherichia coli and Klebsiella pneumonia. 2 
Based on substrate specificity the β-lactamase family 
split into four functional groups: penicillinase, ESBL, 
carbapenemase, and Amp-C enzyme.3,4 The beta-
lactamase (bla) gene is usually found on chromosomes, 
although it would also found in plasmids.5 The ESBL 
coding gene residing in the plasmid is easily transferred 
to other germs, thereby accelerating resistance.6 
Community-acquired infections due to ESBL-producing 
Enterobacteriaceae (EPE) have increased. The flora 
fecal in the community is a vast potential reservoir for 
ESBL.7 Based on a survey conducted by the CDC in 
2013, each year, there are 26,000 infections caused by 
EPE, and around 1,700 of them die.  
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Asymptomatic carriers of ESBL-producing bacteria in 
communities reported in several countries and continents 
with large differences in carrier rates between 
geographic areas and population characteristics studied. 
Incredibly high carrier prevalence rates were also widely 
developed in Thailand (66%), Egypt (63%), and China 
(50%).  8 Low carrier levels shown from Sweden (3%).9 
In Indonesia as its own, a community carrier study by 
Ulla et al. published that 26.8% of healthy Unsoed 
medical participating students were carriers of ESBL-
producing Escherichia coli. Prevalence of ESBL 
Escherichia coli in fecal specimens of 457 traveler 
diarrhea patients in Spain who have traveled to tropical 
and subtropical regions is 17.9% of patients (82/457). 
India seems to be the most visited region and revealed a 
larger number of positive samples. (37.4%).10 
 The current study on the prevalence and risk factors 
of EPE carriers in Indonesia's healthy communities is 
rare. Each result of this study provides evidence for both 
the prevention and control of EPE in the population. 
Based on this context, specific, transparent, observable, 
and sustainable efforts need to be made in a single health 
approach across sectors, including the public health, 
livestock, fisheries, and agriculture sectors, to resolve 
this issue. These efforts involve critical surveillance data 
and strict implementation of field regulations to break 
the chain of EPE deployments. Therefore, prevalence 
data and related risk factors must establish firm policies 
to control antimicrobial resistance, especially EPE. 
 
MATERIALS AND METHODS  
Population and sampling methods  
The population in this study is the healthy people in 
Purwokerto. This research has received approval from 
the Faculty of Medicine's ethics committee, Universitas 
Jenderal Soedirman (Ref: 182/KEPK/VIII/2020). The 
sampling method is consecutive sampling. The 
minimum sample size for this analysis was 75. We 




Participants must fill out a questionnaire containing 
informed consent, name, age, sex, medical records (prior 
intake of antibiotics or antacids, initial hospitalization), 
consumption (milk, yogurt, cheese, meat, freshwater 
fish, seafood, chicken, etc.), and use of public toilets. 
 
Sampling method 
 Amies transport medium (Labware Charuzu) (non-
nutritive medium) tubes to collect all swab specimens. 
 
Isolation and identification  
 Samples isolated in HiCrome ™ ESBL Agar Base 
(Himedia, India) + HiCrome™ ESBL agar supplement 
and incubated for 24 hours at 37º C. Chromogenic 
mixture is used to distinguish the pigment ESBL-
producing organisms. HiCrome™ ESBL Selective 
Supplement (FD278) allows suppressing some 
contaminating microorganisms. ESBL E.coli grow as 
either pink or purple colonies. ESBL producing 
members of the KESC group have bluish-green 















 This research uses an analytic observational study 
with a cross-sectional approach, which emphasizes 
measuring or observing data one time based on the 
dependent variable and the independent variable. 
Univariate analysis of the independent and dependent 
variables to obtain a descriptive picture of the variables 
studied in presentation distribution. Bivariate analysis to 
see the relationship between independent and dependent 
variables uses the Chi-Square or Fisher Exact test for 
categorical variables and the Mann-Whitney U test for 
numerical data. Multivariate analysis conducted with 
multiple logistic regression. Statistical analysis of 
Prevalence and determinants of resistance uses IBM 
SPSS Statistics Version 22.0 for Windows (Armonk, 
NY: IBM Corp). The analysis results described as 
Prevalence Risk (PR), p-value, and 95% Confidence 
Interval (CI). All p-values were 2-tailed, and p <0.05 
would be considered significant. 
 
RESULTS  
 The prevalence of asymptomatic carriers of 
Enterobacteriaceae ESBL from a total of seventy-five 
respondents who participated in this study was 50 
(66.7%). The most common isolate was Escherichia coli 
50 (66.7%) were two strains of organisms (Escherichia 
coli and Klebsiella pneumoniae) in one respondent were 
more often found with a percentage of 29 (38.7%) 
compared to one strain (Escherichia coli) 21 (28%). Most 
of the respondents had a senior high school education 
level, namely 32 (42.7%). (Table 2). Participants in this 
study, 43 (52,3%) were women, and 32 (42,7%) were 
men, with the mean age of the respondents was 32.35 ± 
10.93 years. Women had a 67.4% higher frequency of 
ESBL colonization (29/43) than men 65.6% (21/32), but 
there was no statistically significant difference.  
Table 1. Identification of ESBL producing bacteria 
Organism 
Inoculum 






   






50-100 luxuriant >=50% 
bluish 
green 
Note: (*) Corresponding WDCM numbers.  
NCTC: National Collection of Type Cultures 
ATCC: American Type Culture Collection 
 
Table 2. Respondent Characteristics 
Characteristic Total n(%) 
Culture result  
ESBL + 50 (66.7%) 
ESBL - 25 (33.3%) 
Organism  
Escherichia coli 21 (28%) 
Escherichia  coli and Klebsiella pneumoniae 29 (38.7%) 
Sterile 25 (33.3%) 
Last education  
Primary school 4 (5.3%) 
Junior High 6 (8%) 
High school 32 (42.7%) 
Vocational High School 3 (4%) 
D3 5 (6.7%) 
S1 17 (22.7%) 
S2 7 (9.3%) 
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Subjects who took antacids in the last eight weeks and 
hospital admission in the previous 12 months had a 
higher incidence rate of ESBL carriers than other 
respondents (Table 3). However, the bivariate analysis 
showed no significant differences between these 
variables. In the bivariate analysis, the habits of 
consuming milk, yogurt, cheese, meat, seafood, and raw 
vegetables did not show any significant differences. In 
contrast, for subjects who took antibiotics over the last 
eight weeks, the overall incidence was 100 percent 
(11/11), significantly higher than several other 
respondents who were also asymptomatic carriers of 
Enterobacteriaceae ESBL 60.9 percent (39/64). Where 
PR 0.609. 95% CI (0.501-0.741), which has the meaning 
of this variable, is not a risk factor for the 
Enterobacteriaceae ESBL carriers or is protective; still, 
in multivariate logistic regression analysis, this becomes 
insignificant. Excessive consumption of chicken and 
freshwater fish appeared to become a risk factor for 
Enterobacteriaceae-producing ESBL with Prevalence 
risk, respectively, PR 1.462, 95% CI (1.115-1.918); PR 
1.666, 95% CI  (0.936-2.966) (Table. 3); however, in the 
logistic regression multivariate analysis, it was not 
significant. Participants who do not have the habit of 
using public toilets found to be higher in asymptomatic 
carriers of Enterobacteriaceae ESBL 68.2% (30/44) than 
those who habitually use public restrooms 64.5% 




 Research into the asymptomatic carrier of ESBL E. 
coli is essential because it has significant clinical 
consequences for public health.11 A healthy carrier can 
develop severe urinary tract, intra-abdominal, or 
bloodstream infections in the future.12,13 Mortality rates 
following infection with ESBL E. coli are considerably 
higher.14,15 The last review on carbapenems might be the 
only efficient treatment.16 Often, moderate urinary tract 
infections occur to remain due to enhanced morbidity.17 
The cumulative combined Prevalence of ESBL E. coli 
carriers in the community (2003-2018) was 16.5%.18 
The combined Prevalence shows an increasing trend 
from 2.6% in 2003–2005 to 21.1%  in 2015–2018. The 
highest carrier rates were observed in Southeast Asia 
throughout the period, while Europe was the lowest.19 In 
the research we conducted, especially in Purwokerto, 
there was also an increase in ESBL E. coli carriers trends 
to 66.7% compared to previous studies conducted by a 
research team from the Faculty of Medicine, General 
Soedirman Purwokerto University in 2015 class students 
as much as 26.8%. In some other research, the fecal 
carrier rate of Enterobacteriaceae ESBL is about 62.7% 
among hospitalized patients and 33.8% among 
asymptomatic healthy people. A more frequently 
reported Enterobacteriaceae of ESBL seemed to be 
Escherichia coli (70.3% and 78.4%, in both patients and 
healthy subjects), followed by Klebsiella pneumoniae 
(26.8% and 17.0 %). 20 In our study, most isolates found 
were Escherichia coli 50 isolates (66.7%), most of which 
were found together with Klebsiella pneumoniae or two 
strains in one respondent 29 (38.7%). 
 Hijazi et al., in their study, found that thirty-one of 
the 125 participants (24.8%) were carriers of the 
Enterobacteriaceae ESBL. In the bivariate test, regular 
consumption (3 times per week or more) of milk, yogurt, 
cheese, chicken, or meat showed a significant effect. In 
multivariate logistic regression analysis, beef and 
chicken's routine consumption is also significantly 
related to increased Enterobacteriaceae ESBL carriers; 
the association of dairy products (milk, yogurt, cheese) 
was not significant.7 In our study, frequent consumption 
of chicken and freshwater fish to be a risk factor for the 
carriers of ESBL-producing Enterobacteriaceae (Table. 
3); however, in the logistic regression multivariate 
analysis, it was not significant. In the research developed 
by Otter et al., the risk factor for Enterobacteriaceae 
ESBL carriers among 1633 patients was receiving two or 
more antibiotic courses six months before the 
examination.21 In our study, participants taking 
antibiotics in the last eight weeks had a 100% higher 
prevalence rate (11/11) than some other respondents who 
also were asymptomatic carriers of Enterobacteriaceae 
ESBL 60.9% (39/64) with PR 1.000, 95% CI (0.442-
2.263). The above means that this variable is not a risk 
factor for the Enterobacteriaceae ESBL carriers or is 
protective, but this is not significant in multivariate 
logistic regression analysis. Shitrit et al. in their study 
found that of the 525 patients tested, 56 seemed to be 
positive for ESBL carriers, 4 different risk factors are 
associated: residency in a nursing facility, history of 1-
year previous hospitalization, history of antibiotic 
treatment, and last ESBL carriers. More than 50% of 
patients screened have at least one risk factor. 22 
 
CONCLUSION  
 The prevalence of EPE asymptomatic carriers in the 
community in Purwokerto was 66.7%. These data are 
required to establish firm policies to control antimicrobial 
resistance. Consumption of chicken and freshwater fish 
is not a risk factor for ESBL-producing 
Enterobacteriaceae. However, ESBL remains an 
emerging antimicrobial resistance. 
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ESBL + n 
(%) 
ESBL - n 
(%) 
Bivariate Analysis Multivariate 
Analysis 












Male 32 (42.7%) 21 (42%) 11 (44%)     
Women 43 (57.3%) 29 (58%) 14 (56%)     
Hospital 
admissions in the 
past six months  





Yes 8 (10.7%) 7 (14%) 1 (4%)     
No 67 (89.3%) 43 (86%) 24 (96%)     
Taking antibiotics 
for eight weeks  








Yes 11 (14.7%) 11 (22%) 0 (0%)     
No 64 (85.3%) 39 (78%) 25 (100%)     
Taking antibiotics 
without a doctor's 
prescription 
within six months  





Yes 3 (4%) 2 (4%) 1 (4%)     









Yes 10 (13.3%) 9 (18%) 1 (4%)     
No 65 (86.7%) 41 (82%) 24 (96%)     





Often 21 (28%) 12 (24%) 9 (36%)     
Rarely or  
never 
54 (72%) 38 (76%) 16 (64%)     





Often 7 (9.3%) 7 (14%) 0 (0%)     
Rarely or  
never 
68 (90.7%) 43 (86%) 25 (100%)     





Often 10 (13.3%) 7 (14%) 3 (12%)     
Rarely or  
never 
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Often 29 (38.7%) 20 (40%) 9  (36%)     
Rarely or  
never 
46 (61.3%) 30 (69%) 16 (64%)     
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never 
17 (22.7%) 15 (30%) 2 (8%)     
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66 (88%) 43 (86%) 23 (92%)     
Eating freshwater 
fish 
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Eating raw 
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